Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diagnostic Imaging

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 141 articles:
HTML format
Text format



Single Articles


    August 2018
  1. CIARAVINO V, Cardobi N, DE Robertis R, Capelli P, et al
    CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy.
    Anticancer Res. 2018;38:4889-4895.
    PubMed     Text format     Abstract available


  2. THIEME SF, Collettini F, Sehouli J, Biocca L, et al
    Preoperative Evaluation of Myometrial Invasion in Endometrial Carcinoma: Prospective Intra-individual Comparison of Magnetic Resonance Volumetry, Diffusion-weighted and Dynamic Contrast-enhanced Magnetic Resonance Imaging.
    Anticancer Res. 2018;38:4813-4817.
    PubMed     Text format     Abstract available


  3. NISHIE A, Sugimoto M, Asayama Y, Ishigami K, et al
    Relationship Among Tumor Attenuation Value of Pre-contrast Computed Tomography (CT), Washout Rate and Constituent Cells in Adrenal Adenoma: Proposition of a New Approach for Diagnosing Adrenal Adenoma on Dynamic CT.
    Anticancer Res. 2018;38:4767-4773.
    PubMed     Text format     Abstract available


  4. NAKAMURA M, Suetsugu A, Hasegawa K, Satake T, et al
    Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.
    Anticancer Res. 2018;38:4417-4423.
    PubMed     Text format     Abstract available


  5. MORIMOTO M, Honjo S, Sakamoto T, Uchinaka EI, et al
    Pilot Study of Probe-based Confocal Laser Endomicroscopy with Fluorescein-dripping Method for Liver Tumors.
    Anticancer Res. 2018;38:4775-4781.
    PubMed     Text format     Abstract available


    July 2018
  6. TORATA N, Kubo M, Miura D, Ohuchida K, et al
    Visualizing Energy Charge in Breast Carcinoma Tissues by MALDI Mass-spectrometry Imaging Profiles of Low-molecular-weight Metabolites.
    Anticancer Res. 2018;38:4267-4272.
    PubMed     Text format     Abstract available


  7. BAXA J, Ferda J, Ferdova E, Vojtisek R, et al
    Hybrid Imaging PET/CT with Application of (18)F-Fluorothymidine in Patients with Head and Neck Carcinoma Undergoing Radiotherapy.
    Anticancer Res. 2018;38:4153-4157.
    PubMed     Text format     Abstract available


  8. TUPY R, Mirka H, Mracek J, Priban V, et al
    Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
    Anticancer Res. 2018;38:4149-4152.
    PubMed     Text format     Abstract available


  9. FERDOVA E, Baxa J, Narsanska A, Hes O, et al
    Low-dose High-resolution (18)F-FDG-PET/CT Using Time-of-flight and Point-spread Function Reconstructions: A Role in the Detection of Breast Carcinoma Axillary Lymph Node Metastases.
    Anticancer Res. 2018;38:4145-4148.
    PubMed     Text format     Abstract available


  10. FERDA J, Ferdova E, Baxa J, Finek J, et al
    (18)F-Fluorocholine PET/MRI in Restaging of Prostatic Carcinoma in Relation to PSA Level and Detection of Active Disease.
    Anticancer Res. 2018;38:4139-4143.
    PubMed     Text format     Abstract available


  11. BAXA J, Matouskova T, Ludvik J, Sedlmair M, et al
    Single-source Dual-energy CT as a Part of (18)F-FDG PET/CT: Direct Comparison of Iodine-related and Metabolic Parameters in Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:4131-4137.
    PubMed     Text format     Abstract available


  12. MIRKA H, Duras P, Baxa J, Korcakova E, et al
    Contribution of Computed Tomographic Angiography to Pretreatment Planning of Radio-embolization of Liver Tumors.
    Anticancer Res. 2018;38:3825-3829.
    PubMed     Text format     Abstract available


  13. LIAO CL, Chu YL, Lin HY, Chen CY, et al
    Bisdemethoxycurcumin Suppresses Migration and Invasion of Human Cervical Cancer HeLa Cells via Inhibition of NF-kB, MMP-2 and -9 Pathways.
    Anticancer Res. 2018;38:3989-3997.
    PubMed     Text format     Abstract available


    June 2018
  14. TAKAMORI S, Toyokawa G, Shimokawa M, Kinoshita F, et al
    Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring EGFR Mutation.
    Anticancer Res. 2018;38:3731-3734.
    PubMed     Text format     Abstract available


  15. HAGI T, Nakamura T, Sugino Y, Matsubara T, et al
    Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
    Anticancer Res. 2018;38:3635-3639.
    PubMed     Text format     Abstract available


  16. MATSUMOTO T, Hasebe T, Baba Y, Chosa K, et al
    Feasibility and Safety of CT-guided Intrathoracic and Bone Re-biopsy for Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:3587-3592.
    PubMed     Text format     Abstract available


  17. PIRLAMARLA AK, Tang J, Amin B, Kabarriti R, et al
    Vulvar Melanoma with Isolated Metastasis to the Extraocular Muscles: Case Report and Brief Literature Review.
    Anticancer Res. 2018;38:3763-3766.
    PubMed     Text format     Abstract available


  18. KHOSRAWIPOUR V, Mikolajczyk A, Schubert J, Khosrawipour T, et al
    Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) via Endoscopical Microcatheter System.
    Anticancer Res. 2018;38:3447-3452.
    PubMed     Text format     Abstract available


  19. WANG Q, Lu X, Wang J, Yang Z, et al
    Moesin Up-regulation Is Associated with Enhanced Tumor Progression Imaged Non-invasively in an Orthotopic Mouse Model of Human Glioblastoma.
    Anticancer Res. 2018;38:3267-3272.
    PubMed     Text format     Abstract available


    May 2018
  20. LIAO TY, Liaw CC, Tsui KH, Juan YH, et al
    Renal Pelvis Carcinoma with Renal Vein or Inferior Vena Cava Involvement Linked to Early-onset Lung Metastasis Based on CT Scan Diagnosis.
    Anticancer Res. 2018;38:3187-3192.
    PubMed     Text format     Abstract available


  21. YOSHIDA M, Beppu T, Shiraishi S, Tsuda N, et al
    Liver Function in Areas of Hepatic Venous Congestion After Hepatectomy for Liver Cancer: (99m)Tc-GSA SPECT/CT Fused Imaging Study.
    Anticancer Res. 2018;38:3089-3095.
    PubMed     Text format     Abstract available


  22. WADLE J, Hetjens S, Winter J, Muhlbauer J, et al
    Nephrometry Scores: The Effect of Imaging on Routine Read-out and Prediction of Outcome of Nephron-sparing Surgery.
    Anticancer Res. 2018;38:3037-3041.
    PubMed     Text format     Abstract available


  23. PORPIGLIA F, DE Luca S, Checcucci E, Garrou D, et al
    Comparing Image-guided targeted Biopsies to Radical Prostatectomy Specimens for Accurate Characterization of the Index Tumor in Prostate Cancer.
    Anticancer Res. 2018;38:3043-3047.
    PubMed     Text format     Abstract available


  24. MEYER HJ, Wienke A, Surov A
    Correlation Between Ktrans and Microvessel Density in Different Tumors: A Meta-analysis.
    Anticancer Res. 2018;38:2945-2950.
    PubMed     Text format     Abstract available


    April 2018
  25. PARK HL, Kim KY, Park JS, Shin JE, et al
    Clinicopathological Analysis of Ultrasound-guided Vacuum-assisted Breast Biopsy for the Diagnosis and Treatment of Breast Disease.
    Anticancer Res. 2018;38:2455-2462.
    PubMed     Text format     Abstract available


  26. PEPE P, Pepe G, Pepe L, Garufi A, et al
    Cost-effectiveness of Multiparametric MRI in 800 Men Submitted to Repeat Prostate Biopsy: Results of a Public Health Model.
    Anticancer Res. 2018;38:2395-2398.
    PubMed     Text format     Abstract available


  27. MAEHARA J, Nishie A, Asayama Y, Ishigami K, et al
    Tumor Enhancement on Dynamic CT: A Predictive Factor for Recurrence After Nephrectomy in Localized T1 Clear Cell Renal Cell Carcinoma.
    Anticancer Res. 2018;38:2377-2383.
    PubMed     Text format     Abstract available


  28. TUOHINEN SS, Keski-Pukkila K, Skytta T, Huhtala H, et al
    Radiotherapy-induced Early ECG Changes and Their Comparison with Echocardiography in Patients with Early-stage Breast Cancer.
    Anticancer Res. 2018;38:2207-2215.
    PubMed     Text format     Abstract available


  29. BIANCONI F, Fravolini ML, Bello-Cerezo R, Minestrini M, et al
    Evaluation of Shape and Textural Features from CT as Prognostic Biomarkers in Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:2155-2160.
    PubMed     Text format     Abstract available


  30. SUETSUGU A, Shimizu M, Saji S, Moriwaki H, et al
    Visualizing the Tumor Microenvironment by Color-coded Imaging in Orthotopic Mouse Models of Cancer.
    Anticancer Res. 2018;38:1847-1857.
    PubMed     Text format     Abstract available


  31. FRIEDRICH RE, Reul A
    Periapical Cemento-osseous Dysplasia Is Rarely Diagnosed on Orthopantomograms of Patients with Neurofibromatosis Type 1 and Is Not a Gender-specific Feature of the Disease.
    Anticancer Res. 2018;38:2277-2284.
    PubMed     Text format     Abstract available


    March 2018
  32. ZUGOR V, VON Brandenstein M, Akbarov I, Porres D, et al
    Preoperative Stating of Pelvic Lymph Nodes in Prostate Cancer Patients via Endorectal Magnetic Resonance Imaging.
    Anticancer Res. 2018;38:1763-1765.
    PubMed     Text format     Abstract available


  33. UJHELYI M, Pukancsik D, Kelemen P, Kovacs E, et al
    Barriers to Organized Mammography Screening Programs in Hungary: A Questionnaire-based Study of 3,313 Women.
    Anticancer Res. 2018;38:1727-1734.
    PubMed     Text format     Abstract available


  34. SUROV A, Leifels L, Meyer HJ, Winter K, et al
    Associations Between Histogram Analysis DCE MRI Parameters and Complex (18)F-FDG-PET Values in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1637-1642.
    PubMed     Text format     Abstract available


  35. SU W, Miles BA, Posner M, Som P, et al
    Surveillance Imaging in HPV-related Oropharyngeal Cancer.
    Anticancer Res. 2018;38:1525-1529.
    PubMed     Text format     Abstract available


  36. TOYA R, Saito T, Shiraishi S, Kai Y, et al
    Dose-function Histogram Evaluation Using (99m)Tc-GSA SPECT/CT Images for Stereotactic Body Radiation Therapy Planning for Hepatocellular Carcinoma Patients: A Dosimetric Parameter Comparison.
    Anticancer Res. 2018;38:1511-1516.
    PubMed     Text format     Abstract available


  37. HOLMBERG AR, Marquez M, Lennartsson L, Meurling L, et al
    Synthesis and Binding of a Novel PSMA-specific Conjugate.
    Anticancer Res. 2018;38:1531-1537.
    PubMed     Text format     Abstract available


    February 2018
  38. TANADINI-LANG S, Bogowicz M, Veit-Haibach P, Huellner M, et al
    Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer.
    Anticancer Res. 2018;38:685-690.
    PubMed     Text format     Abstract available


  39. LUCZYNSKA E, Niemiec J, Heinze S, Adamczyk A, et al
    Intensity and Pattern of Enhancement on CESM: Prognostic Significance and its Relation to Expression of Podoplanin in Tumor Stroma - A Preliminary Report.
    Anticancer Res. 2018;38:1085-1095.
    PubMed     Text format     Abstract available


  40. HORTON CE, Kamal M, Leslie M, Zhang R, et al
    Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans.
    Anticancer Res. 2018;38:1073-1076.
    PubMed     Text format     Abstract available


  41. HAUSMANN D, Liu J, Budjan J, Reichert M, et al
    Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s(2)) DWI for Response Assessment in Rectal Cancer.
    Anticancer Res. 2018;38:969-978.
    PubMed     Text format     Abstract available


  42. SEMKOVA S, Nikolova B, Zhelev Z, Tsoneva I, et al
    Loading Efficiency of Polymersomes with Contrast Agents and their Intracellular Delivery: Quantum Dots Versus Organic Dyes.
    Anticancer Res. 2018;38:825-831.
    PubMed     Text format     Abstract available


    January 2018
  43. MIRKA H, Baxa J, Hora M, Hes O, et al
    Iodine Content Analysis Using Dual-Energy Computed Tomography as a Biomarker of Transitional Cell Carcinoma, an Experience with Separation of the Clotted Blood and Tumorous Tissue.
    Anticancer Res. 2018;38:541-545.
    PubMed     Text format     Abstract available


  44. SERTDEMIR M, Weidner AM, Schoenberg SO, Morelli JN, et al
    Is There a Role for Functional MRI for the Assessment of Extracapsular Extension in Prostate Cancer?
    Anticancer Res. 2018;38:427-432.
    PubMed     Text format     Abstract available


  45. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Text format     Abstract available


  46. NAKUZ TS, Berger E, El-Rabadi K, Wadsak W, et al
    Clinical Value of (18)F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma.
    Anticancer Res. 2018;38:353-358.
    PubMed     Text format     Abstract available


  47. KISHIMOTO S, Aoki H, Suzuki R, Inoue M, et al
    Angiographic Evaluation of Vascular Damage in Rat Liver After Administration of Epirubicin or Miriplatin.
    Anticancer Res. 2018;38:247-251.
    PubMed     Text format     Abstract available


  48. KIYUNA T, Tome Y, Uehara F, Murakami T, et al
    Tumor-targeting Salmonella typhimurium A1-R Inhibits Osteosarcoma Angiogenesis in the In Vivo Gelfoam(R) Assay Visualized by Color-coded Imaging.
    Anticancer Res. 2018;38:159-164.
    PubMed     Text format     Abstract available


  49. SOTTERO TL, Girard EJ, Myers C, Hopping G, et al
    Pacifastin-derived Peptides Target Tumors for Use in In Vivo Imaging.
    Anticancer Res. 2018;38:51-60.
    PubMed     Text format     Abstract available


  50. CHANG LW, Hung SC, Hu JC, Chiu KY, et al
    Retzius-sparing Robotic-assisted Radical Prostatectomy Associated with Less Bladder Neck Descent and Better Early Continence Outcome.
    Anticancer Res. 2018;38:345-351.
    PubMed     Text format     Abstract available


    December 2017
  51. TAKADA K, Toyokawa G, Tagawa T, Kohashi K, et al
    Association Between PD-L1 Expression and Metabolic Activity on (18)F-FDG PET/CT in Patients with Small-sized Lung Cancer.
    Anticancer Res. 2017;37:7073-7082.
    PubMed     Text format     Abstract available


  52. MIRKA H, Tupy R, Narsanska A, Hes O, et al
    Pre-surgical Multiparametric Assessment of Breast Lesions Using 3-Tesla Magnetic Resonance.
    Anticancer Res. 2017;37:6965-6970.
    PubMed     Text format     Abstract available


  53. HOFFMANN MA, Taymoorian K, Ruf C, Gerhards A, et al
    Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer.
    Anticancer Res. 2017;37:6871-6877.
    PubMed     Text format     Abstract available


  54. AULA H, Skytta T, Tuohinen S, Luukkaala T, et al
    Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level - A Prospective Observational Study.
    Anticancer Res. 2017;37:6815-6824.
    PubMed     Text format     Abstract available


  55. ERBER R, Stohr R, Herlein S, Giedl C, et al
    Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer(R) Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer.
    Anticancer Res. 2017;37:6771-6778.
    PubMed     Text format     Abstract available


    October 2017

  56. Applications of Mass Spectrometry Imaging to Cancer, Volume 134. 1st Edition.
    Anticancer Res. 2017;37:5908.
    PubMed     Text format    


  57. ANGELOPOULOU MK, Mosa E, Pangalis GA, Rondogianni P, et al
    The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.
    Anticancer Res. 2017;37:5727-5736.
    PubMed     Text format     Abstract available


  58. MORINE Y, Enkhbold C, Imura S, Ikemoto T, et al
    Accurate Estimation of Functional Liver Volume Using Gd-EOB-DTPA MRI Compared to MDCT/99mTc-SPECT Fusion Imaging.
    Anticancer Res. 2017;37:5693-5700.
    PubMed     Text format     Abstract available


  59. RATHMANN N, Kara K, Budjan J, Henzler T, et al
    Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Anticancer Res. 2017;37:5681-5685.
    PubMed     Text format     Abstract available


  60. BAKALOVA R, Zhelev Z, Shibata S, Nikolova B, et al
    Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Versus "Onco-Suppressive" Reactive Oxygen Species.
    Anticancer Res. 2017;37:5449-5458.
    PubMed     Text format     Abstract available


  61. GIGLI S, Amabile MI, DI Pastena F, DE Luca A, et al
    Lipofilling Outcomes Mimicking Breast Cancer Recurrence: Case Report and Update of the Literature.
    Anticancer Res. 2017;37:5395-5398.
    PubMed     Text format     Abstract available


  62. ANGELIERI F, Yujra VQ, Oshima CTF, Ribeiro DA, et al
    Do Dental X-Rays Induce Genotoxicity and Cytotoxicity in Oral Mucosa Cells? A Critical Review.
    Anticancer Res. 2017;37:5383-5388.
    PubMed     Text format     Abstract available


    September 2017
  63. THEODORE C, Levaillant JM, Capmas P, Chabi N, et al
    MRI and Ultrasound Fusion Imaging for Cervical Cancer.
    Anticancer Res. 2017;37:5079-5085.
    PubMed     Text format     Abstract available


  64. EICHLER C, Abrar S, Puppe J, Arndt M, et al
    Detection of Ductal Carcinoma In Situ by Ultrasound and Mammography: Size-dependent Inaccuracy.
    Anticancer Res. 2017;37:5065-5070.
    PubMed     Text format     Abstract available


  65. WU X, Reinikainen P, Kapanen M, Vierikko T, et al
    Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
    Anticancer Res. 2017;37:5027-5032.
    PubMed     Text format     Abstract available


  66. WIKSTROM J, Isacsson U, Johansson B, Lennernas BO, et al
    Magnetic Resonance Compatibility of a Transponder Aimed for Radiotherapy Positioning - A Phantom Study.
    Anticancer Res. 2017;37:4993-4996.
    PubMed     Text format     Abstract available


  67. KRAMMER J, Stepniewski K, Kaiser CG, Brade J, et al
    Value of Additional Digital Breast Tomosynthesis for Preoperative Staging of Breast Cancer in Dense Breasts.
    Anticancer Res. 2017;37:5255-5261.
    PubMed     Text format     Abstract available


    August 2017
  68. WANG Y, Li D, Liu R, Jia C, et al
    Application of Ultrasound-guided Core Needle Biopsy in the Diagnosis of T3 or T4 Stage Laryngeal and Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:4563-4567.
    PubMed     Text format     Abstract available


  69. YUAN Z, Qu X, Zhang ZT, Jiang WG, et al
    Application of Localization and Needle Placement Guided by Mammographic, Ultrasound and Fiberoptic Ductoscopy for Resection of Non-palpable Breast Lesions.
    Anticancer Res. 2017;37:4523-4527.
    PubMed     Text format     Abstract available


  70. TANG K, Sui LL, Xu G, Zhang T, et al
    Effects of Different Palliative Jaundice Reducing Methods on Immunologic Functions in Patients with Advanced Malignant Obstructive Jaundice.
    Anticancer Res. 2017;37:4665-4670.
    PubMed     Text format     Abstract available


  71. JIN L, Zhu L, Li S, Zeng Y, et al
    Predictors of Malignancy for Female Patients with Suspicious Nipple Discharge: A Retrospective Study.
    Anticancer Res. 2017;37:4655-4658.
    PubMed     Text format     Abstract available


  72. DONG W, Li B, Wang J, Song Y, et al
    Exploration of the Radiotherapeutic Clinical Target Volume Delineation for Gastric Cancer from Lymph Node Metastases.
    Anticancer Res. 2017;37:4629-4634.
    PubMed     Text format     Abstract available


    July 2017
  73. HASEGAWA K, Suetsugu A, Nakamura M, Matsumoto T, et al
    Imaging the Role of Multinucleate Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in Peritoneal Metastasis in Mouse Models.
    Anticancer Res. 2017;37:3435-3440.
    PubMed     Text format     Abstract available


  74. SUROV A, Meyer HJ, Wienke A
    Correlation Between Minimum Apparent Diffusion Coefficient (ADCmin) and Tumor Cellularity: A Meta-analysis.
    Anticancer Res. 2017;37:3807-3810.
    PubMed     Text format     Abstract available


  75. MESCHER C, Ding C, Defor T, Konety S, et al
    Left Ventricular Ejection Fraction Screening and Clinical Decision-making in Metastatic HER2-positive Breast Cancer.
    Anticancer Res. 2017;37:3751-3755.
    PubMed     Text format     Abstract available


    June 2017
  76. PEPE P, Garufi A, Priolo GD, Pennisi M, et al
    Multiparametric MRI/TRUS Fusion Prostate Biopsy: Advantages of a Transperineal Approach.
    Anticancer Res. 2017;37:3291-3294.
    PubMed     Text format     Abstract available


  77. FITZPATRICK C, Lynch O, Marignol L
    68Ga-PSMA-PET/CT Has a Role in Detecting Prostate Cancer Lesions in Patients with Recurrent Disease.
    Anticancer Res. 2017;37:2753-2760.
    PubMed     Text format     Abstract available


  78. SCHERZ A, Feller K, Berezowska S, Genitsch V, et al
    Successful Treatment of Pituitary Germinoma with Etoposide, Cisplatin, Vincristine, Methotrexate and Bleomycin Chemotherapy Without Radiotherapy.
    Anticancer Res. 2017;37:3111-3115.
    PubMed     Text format     Abstract available


    May 2017
  79. KOLLA BC, Roy SS, Duval S, Weisdorf D, et al
    Cardiac Imaging Methods for Chemotherapy-related Cardiotoxicity Screening and Related Radiation Exposure: Current Practice and Trends.
    Anticancer Res. 2017;37:2445-2449.
    PubMed     Text format     Abstract available


  80. PRESL J, Ovesna P, Novotny Z, Vlasak P, et al
    Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.
    Anticancer Res. 2017;37:2697-2702.
    PubMed     Text format     Abstract available


  81. EISTERER W, Piringer G, DE Vries A, Ofner D, et al
    Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
    Anticancer Res. 2017;37:2683-2691.
    PubMed     Text format     Abstract available


  82. KIM JY, Na K, Kim HS
    Clinicopathological Characteristics of Mitotically-active Cellular Fibroma of the Ovary: A Single-institutional Experience.
    Anticancer Res. 2017;37:2557-2564.
    PubMed     Text format     Abstract available


  83. MANDELKOW R, Gumbel D, Ahrend H, Kaul A, et al
    Detection and Quantification of Nuclear Morphology Changes in Apoptotic Cells by Fluorescence Microscopy and Subsequent Analysis of Visualized Fluorescent Signals.
    Anticancer Res. 2017;37:2239-2244.
    PubMed     Text format     Abstract available


    April 2017
  84. KAISER CG, Herold M, Krammer J, Baltzer P, et al
    Prognostic Value of "Prepectoral Edema" in MR-mammography.
    Anticancer Res. 2017;37:1989-1995.
    PubMed     Text format     Abstract available


  85. HARADA N, Yoshizumi T, Maeda T, Kayashima H, et al
    Preoperative Pancreatic Stiffness by Real-time Tissue Elastography to Predict Pancreatic Fistula After Pancreaticoduodenectomy.
    Anticancer Res. 2017;37:1909-1915.
    PubMed     Text format     Abstract available


    March 2017

  86. Oncologic Imaging: Urology.
    Anticancer Res. 2017;37:1544.
    PubMed     Text format    


  87. TOYOKAWA G, Takada K, Okamoto T, Kozuma Y, et al
    Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer.
    Anticancer Res. 2017;37:1393-1401.
    PubMed     Text format     Abstract available


  88. D'ONOFRIO M, Cingarlini S, Ortolani S, Crosara S, et al
    Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment.
    Anticancer Res. 2017;37:1305-1311.
    PubMed     Text format     Abstract available


  89. HENKENBERENS C, VON Klot CA, Ross TL, Bengel FM, et al
    68Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic Therapy.
    Anticancer Res. 2017;37:1273-1279.
    PubMed     Text format     Abstract available


  90. SCIALPI M, Prosperi E, D'Andrea A, Martorana E, et al
    Biparametric versus Multiparametric MRI with Non-endorectal Coil at 3T in the Detection and Localization of Prostate Cancer.
    Anticancer Res. 2017;37:1263-1271.
    PubMed     Text format     Abstract available


  91. ELLIS-CALEO T, Hegde JV, Bath S, Mesko S, et al
    Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate Cancer.
    Anticancer Res. 2017;37:1237-1242.
    PubMed     Text format     Abstract available


  92. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    MIC1/GDF15 as a Bone Metastatic Disease Biomarker.
    Anticancer Res. 2017;37:1501-1505.
    PubMed     Text format     Abstract available


  93. LAWSON BO, Khong HT
    Narcoleptic-like Episodes in a Patient Receiving Pegylated Interferon-alpha 2b: A Case Report and Review of Literature.
    Anticancer Res. 2017;37:1365-1368.
    PubMed     Text format     Abstract available


  94. IIZUKA D, Sasatani M, Barcellos-Hoff MH, Kamiya K, et al
    Hydrogen Peroxide Enhances TGFbeta-mediated Epithelial-to-Mesenchymal Transition in Human Mammary Epithelial MCF-10A Cells.
    Anticancer Res. 2017;37:987-995.
    PubMed     Text format     Abstract available


  95. DAI X, Liu D, Liu M, Zhang X, et al
    Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
    Anticancer Res. 2017;37:979-986.
    PubMed     Text format     Abstract available


    February 2017
  96. LIBERALE G, Lecocq C, Garcia C, Muylle K, et al
    Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Anticancer Res. 2017;37:929-934.
    PubMed     Text format     Abstract available


  97. TOYOKAWA G, Kozuma Y, Matsubara T, Haratake N, et al
    Radiological Features of the Surgically Resected Small-sized Small-cell Lung Cancer on Computed Tomography.
    Anticancer Res. 2017;37:877-881.
    PubMed     Text format     Abstract available


  98. SASAKI K, Uchikado Y, Okumura H, Omoto I, et al
    Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2017;37:859-864.
    PubMed     Text format     Abstract available


  99. SALMINEN E, Niiniviita H, Jarvinen H, Heinavaara S, et al
    Cancer Death Risk Related to Radiation Exposure from Computed Tomography Scanning Among Testicular Cancer Patients.
    Anticancer Res. 2017;37:831-834.
    PubMed     Text format     Abstract available


  100. ILENKO A, Sergent F, Mercuzot A, Zitoun M, et al
    Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?
    Anticancer Res. 2017;37:903-907.
    PubMed     Text format     Abstract available


  101. ROSARIO M, Takeuchi A, Yamamoto N, Hayashi K, et al
    Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
    Anticancer Res. 2017;37:749-754.
    PubMed     Text format     Abstract available


  102. KLEIN F, Denecke T, Faber W, Jurgensen C, et al
    DNA Cytometry for Differentiation Between Low- and Medium-grade Dysplasia in Intraductal Papillary Mucinous Neoplasms.
    Anticancer Res. 2017;37:735-740.
    PubMed     Text format     Abstract available


    January 2017
  103. ATTENBERGER UI, Ong MM, Rathmann N, Doyon F, et al
    mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer.
    Anticancer Res. 2017;37:215-222.
    PubMed     Text format     Abstract available


    December 2016
  104. STRANDBERG S, Karlsson CT, Ogren M, Axelsson J, et al
    11C-Acetate-PET/CT Compared to 99mTc-HDP Bone Scintigraphy in Primary Staging of High-risk Prostate Cancer.
    Anticancer Res. 2016;36:6475-6479.
    PubMed     Text format     Abstract available


  105. YAMAGUCHI H, Hori M, Suzuki O, Seo Y, et al
    Clinical Significance of the Apparent Diffusion Coefficient Ratio in Prostate Cancer Treatment with Intensity-modulated Radiotherapy.
    Anticancer Res. 2016;36:6551-6556.
    PubMed     Text format     Abstract available


    November 2016
  106. KOBAYASHI M, Huang CL, Sonobe M, Kikuchi R, et al
    Ad-shWnt2b Vector Therapy Demonstrates Antitumor Activity in Orthotopic Intrapleural Models as Monitored with the In Vitro Imaging System (IVIS).
    Anticancer Res. 2016;36:5887-5893.
    PubMed     Text format     Abstract available


  107. ICHIHARA H, Okumura M, Matsumoto Y
    Therapeutic Effects of Hybrid Liposomes Against Xenograft Mouse Model of Colorectal Cancer In Vivo Due to Long-term Accumulation.
    Anticancer Res. 2016;36:5875-5882.
    PubMed     Text format     Abstract available


    October 2016
  108. KUDOU M, Shiozaki A, Fujiwara H, Konishi H, et al
    Efficacy of PET-CT in the Diagnosis and Treatment of Recurrence After Esophageal Cancer Surgery.
    Anticancer Res. 2016;36:5473-5480.
    PubMed     Text format     Abstract available


  109. WALDREP AR, Avery EJ, Rose FF Jr, Midathada MV, et al
    Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy.
    Anticancer Res. 2016;36:5389-5395.
    PubMed     Text format     Abstract available


  110. KLEMENTIEVA NV, Snopova LB, Prodanets NN, Furman OE, et al
    Fluorescence Imaging of Actin Fine Structure in Tumor Tissues Using SiR-Actin Staining.
    Anticancer Res. 2016;36:5287-5294.
    PubMed     Text format     Abstract available


    September 2016
  111. LIBERALE G, Vankerckhove S, Galdon MG, Larsimont D, et al
    Sentinel Lymph Node Detection by Blue Dye Versus Indocyanine Green Fluorescence Imaging in Colon Cancer.
    Anticancer Res. 2016;36:4853-8.
    PubMed     Text format     Abstract available


  112. PORPIGLIA F, DE Luca S, Passera R, Manfredi M, et al
    Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
    Anticancer Res. 2016;36:4833-9.
    PubMed     Text format     Abstract available


  113. SHIN YR, Kim KA, Im S, Hwang SS, et al
    Prediction of KRAS Mutation in Rectal Cancer Using MRI.
    Anticancer Res. 2016;36:4799-804.
    PubMed     Text format     Abstract available


  114. PROVOST C, Prignon A, Cazes A, Combaret V, et al
    68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
    Anticancer Res. 2016;36:4459-66.
    PubMed     Text format     Abstract available


  115. HASEGAWA K, Suetsugu A, Nakamura M, Matsumoto T, et al
    Color-coded Imaging Enables Fluorescence-guided Surgery to Resect the Tumor Along with the Tumor Microenvironment in a Syngeneic Mouse Model of EL-4 Lymphoma.
    Anticancer Res. 2016;36:4443-8.
    PubMed     Text format     Abstract available


  116. ATANASOVA S, Nikolova B, Murayama S, Stoyanova E, et al
    Electroinduced Delivery of Hydrogel Nanoparticles in Colon 26 Cells, Visualized by Confocal Fluorescence System.
    Anticancer Res. 2016;36:4601-6.
    PubMed     Text format     Abstract available


  117. KHOSRAWIPOUR V, Khosrawipour T, Falkenstein TA, Diaz-Carballo D, et al
    Evaluating the Effect of Micropump(c) Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model.
    Anticancer Res. 2016;36:4595-600.
    PubMed     Text format     Abstract available


  118. NISHIMURA M, Murayama Y, Harada K, Kamada Y, et al
    Photodynamic Diagnosis of Hepatocellular Carcinoma Using 5-Aminolevulinic Acid.
    Anticancer Res. 2016;36:4569-74.
    PubMed     Text format     Abstract available


  119. STANKEVICIUS V, Vasauskas G, Noreikiene R, Kuodyte K, et al
    Extracellular Matrix-dependent Pathways in Colorectal Cancer Cell Lines Reveal Potential Targets for Anticancer Therapies.
    Anticancer Res. 2016;36:4559-67.
    PubMed     Text format     Abstract available


  120. MATSUMOTO T, Suetsugu A, Hasegawa K, Nakamura M, et al
    A Mouse Model of Fluorescent Protein-expressing Disseminated Peritoneal Lymphoma for Fluorescence-guided Surgery.
    Anticancer Res. 2016;36:4483-7.
    PubMed     Text format     Abstract available


    August 2016

  121. PET/CT in Neuroendocrine Tumors.
    Anticancer Res. 2016;36:4375-6.
    PubMed     Text format    


  122. LUCZYNSKA E, Heinze S, Adamczyk A, Rys J, et al
    Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Anticancer Res. 2016;36:4359-66.
    PubMed     Text format     Abstract available


  123. ZUGOR V, Kuhn R, Engelhard K, Poth S, et al
    The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
    Anticancer Res. 2016;36:4279-83.
    PubMed     Text format     Abstract available


  124. EL-RABADI K, Weber M, Mayerhofer M, Nakuz T, et al
    Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.
    Anticancer Res. 2016;36:4187-93.
    PubMed     Text format     Abstract available


  125. DE FELICE F, Musio D, Bulzonetti N, Maghella F, et al
    Target Volume Delineation Based on Diffusion-weighted magnetic Resonance Imaging for Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2016;36:4181-5.
    PubMed     Text format     Abstract available


  126. KUMASHIRO R, Konishi K, Chiba T, Akahoshi T, et al
    Integrated Endoscopic System Based on Optical Imaging and Hyperspectral Data Analysis for Colorectal Cancer Detection.
    Anticancer Res. 2016;36:3925-32.
    PubMed     Text format     Abstract available


  127. SUETSUGU A, Matsumoto T, Hasegawa K, Nakamura M, et al
    Color-coded Live Imaging of Heterokaryon Formation and Nuclear Fusion of Hybridizing Cancer Cells.
    Anticancer Res. 2016;36:3827-31.
    PubMed     Text format     Abstract available


  128. BUDJAN J, Sauter EA, Morelli JN, Nolden M, et al
    Semi-automatic Volumetric Measurement of Treatment Response in Hepatocellular Carcinoma After Trans-arterial Chemoembolization.
    Anticancer Res. 2016;36:4353-8.
    PubMed     Text format     Abstract available


  129. ZUGOR V, Poth S, Kuhn R, Bernat MM, et al
    Is an Extended Prostate Biopsy Scheme Associated with an Improvement in the Accuracy Between the Biopsy Gleason Score and Radical Prostatectomy Pathology? A Multivariate Analysis.
    Anticancer Res. 2016;36:4285-8.
    PubMed     Text format     Abstract available


  130. FRIEDRICH RE, Nuding MA
    Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Anticancer Res. 2016;36:4095-121.
    PubMed     Text format     Abstract available


  131. TOME Y, Yano S, Sugimoto N, Mii S, et al
    Use of alphav Integrin Linked to Green Fluorescent Protein in Osteosarcoma Cells and Confocal Microscopy to Image Molecular Dynamics During Lung Metastasis in Nude Mice.
    Anticancer Res. 2016;36:3811-6.
    PubMed     Text format     Abstract available


    July 2016
  132. SHIMAMURA Y, Tamatani D, Kuniyasu S, Mizuki Y, et al
    5-Aminolevulinic Acid Enhances Ultrasound-mediated Antitumor Activity via Mitochondrial Oxidative Damage in Breast Cancer.
    Anticancer Res. 2016;36:3607-12.
    PubMed     Text format     Abstract available


  133. YOKOYAMA J, Ishibashi K, Shiramizu H, Ohba S, et al
    Impact of Endoscopic Indocyanine Green Fluorescence Imaging on Superselective Intra-arterial Chemotherapy for Recurrent Cancer of the Skull Base.
    Anticancer Res. 2016;36:3419-24.
    PubMed     Text format     Abstract available


  134. FROSINA G
    Non-routine Tracers for PET Imaging of High-grade Glioma.
    Anticancer Res. 2016;36:3253-60.
    PubMed     Text format     Abstract available


    June 2016
  135. VERNUCCIO F, Taibbi A, Picone D, LA Grutta L, et al
    Imaging of Gastrointestinal Stromal Tumors: From Diagnosis to Evaluation of Therapeutic Response.
    Anticancer Res. 2016;36:2639-48.
    PubMed     Text format     Abstract available


  136. GORKA E, Fabo D, Gezsi A, Czirbesz K, et al
    Distance from Primary Tumor Is the Strongest Predictor for Early Onset of Brain Metastases in Melanoma.
    Anticancer Res. 2016;36:3065-9.
    PubMed     Text format     Abstract available


  137. MIYAMOTO J, Michaud AL, Harandi NK, Kim EJ, et al
    The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning.
    Anticancer Res. 2016;36:3013-7.
    PubMed     Text format     Abstract available


  138. RATHMANN N, Budjan J, Mari F, Grimm R, et al
    Semiautomatic Whole-lesion Apparent Diffusion Coefficient Assessment for Early Prediction of Liver Tumor Response to Radioembolization.
    Anticancer Res. 2016;36:2961-6.
    PubMed     Text format     Abstract available


    May 2016
  139. BACALBASA N, Balescu I, Dragan I, Banceanu G, et al
    Endometrial Adenocarcinoma Presenting as Hematometra with Underlying Thickened Endometrial Lining in a Postmenopausal Woman - A Case Report.
    Anticancer Res. 2016;36:2353-7.
    PubMed     Text format     Abstract available


  140. MA X, Wu YI, Yang X, Yang S, et al
    A Novel 1,2-Dihydroquinoline Anticancer Agent and Its Delivery to Tumor Cells Using Cationic Liposomes.
    Anticancer Res. 2016;36:2105-11.
    PubMed     Text format     Abstract available


    March 2016
  141. GIORGAKIS E, Ramesh B, Kamali-Dashtarzheneh A, Fusai GK, et al
    Demonstration of Calreticulin Expression in Hamster Pancreatic Adenocarcinoma with the Use of Fluorescent Gold Quantum Dots.
    Anticancer Res. 2016;36:861-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diagnostic Imaging is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: